로딩 중…
지수 로딩 중…
Rhythm Pharmaceuticals, Inc.
RYTM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$102.78+3.56%
2026-08-03
Financials
Valuation Metrics
Rhythm Pharmaceuticals, Inc.'s Market Cap is $7.04B. At end of 2025 it was $7.16B. Ranked #1155 of 3,112 in US market (top 37%), #376 of 1,445 on NASDAQ (top 26%), #63 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 23%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $7.04B | US#1,155/3,112 Sec#63/269 |
| Revenue | $217M | US#2,660/3,112 Sec#112/269 |
| Net Income | $-203M | US—/3,112 Sec—/269 |
| Total Assets | $442M | US#2,791/3,112 Sec#172/269 |
| Net Assets | $123M | US#2,852/3,112 Sec#217/269 |
| Value | ||
| P/B | 57.31x | US#2,938/3,112 Sec#252/269 |
| P/S | 32.44x | US#2,858/3,112 Sec#161/269 |
| FCF Yield | -1.71% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -164.91% | US#2,897/3,112 Sec#233/269 |
| ROA | -45.82% | US#2,952/3,112 Sec#207/269 |
| Op. Margin | -90.89% | US#2,818/3,112 Sec#122/269 |
| Revenue Growth | 83.81% | US#179/3,112 Sec#37/269 |
| Financial Health | ||
| Debt Ratio | 259.88% | US#2,007/3,112 Sec#212/269 |
| Total Debt | $227M | US#2,139/3,112 Sec#87/269 |
| FCF | $-120M | US#2,625/3,112 Sec#166/269 |
| Cash | $62M | US#2,485/3,112 Sec#213/269 |
| Current Ratio | 4.17x | US#577/3,112 Sec#165/269 |
| Performance | ||
| 1Y Return | 16.40% | US#1,649/3,112 Sec#174/269 |
| 1M Return | -9.98% | US#2,595/3,112 Sec#164/269 |
| From 52W High | -15.89% | US#1,464/3,112 Sec#85/269 |
| 1Y MDD | -35.54% | US#1,719/3,112 Sec#114/269 |
| Trading | ||
| Volume | 948,502 shares | US#1,529/3,112 Sec#150/269 |
| Trading Value | $96M | US#933/3,112 Sec#56/269 |
| Per Share | ||
| EPS | $-2.94 | US—/3,112 Sec—/269 |
| BPS | $2.08 | US#2,497/3,112 Sec#174/269 |